|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Other expense, net | |||||
| Interest income, net | |||||
| Interest expense | |||||
| Total other income | |||||
| Net loss before income taxes and loss from equity method investment | |||||
| Income tax expense | |||||
| Loss from equity method investment | |||||
| Net loss | |||||
| Other comprehensive loss: | |||||
| Unrealized gain on available-for-sale securities | |||||
| Comprehensive loss | |||||
| Net loss per common share | |||||
| Net loss per common share - basic (in dollars per share) | |||||
| Net loss per common share - diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding | |||||
| Weighted-average common shares outstanding - basic (in shares) | |||||
| Weighted-average common shares outstanding - diluted (in shares) |
Loading...